Pacific Biosciences of California Inc (NASDAQ:PACB) shares, rose in value, with the stock price down by -10.56% to the previous day’s close as strong demand from buyers drove the stock to $1.62.
Actively observing the price movement in the recent trading, the stock is buoying the session at $1.81, falling within a range of $1.5601 and $1.7698. The value of beta (5-year monthly) is 2.009. Referring to stock’s 52-week performance, its high was $7.50, and the low was $1.16. On the whole, PACB has fluctuated by -16.12% over the past month.
With the market capitalization of Pacific Biosciences of California Inc currently standing at about $443.35 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 155.39M, with a low estimate of 39.92M and a high estimate of 42M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 40.68M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PACB’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of PACB currently trading nearly -13.06% and -15.62% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 39.59, while the 7-day volatility ratio is showing 9.80% which for the 30-day chart, stands at 8.79%. Furthermore, Pacific Biosciences of California Inc (PACB)’s beta value is 1.93, and its average true range (ATR) is 0.18.
A comparison of Pacific Biosciences of California Inc (PACB) with its peers suggests the former has fared considerably weaker in the market. PACB showed an intraday change of -10.56% in today’s session so far, and over the past year, it shrunk by -76.47%%.
Data on historical trading for Pacific Biosciences of California Inc (NASDAQ:PACB) indicates that the trading volumes over the past 10 days have averaged 11.67 and over the past 3 months, they’ve averaged 10.14 million. According to company’s latest data on outstanding shares, there are 273.81 million shares outstanding.
Nearly 11.69% of Pacific Biosciences of California Inc’s shares belong to company insiders and institutional investors own 83.26% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 56.85 million shares as on 2024-12-31, resulting in a short ratio of 6.69. According to the data, the short interest in Pacific Biosciences of California Inc (PACB) stood at 2200.00 of shares outstanding as of 2024-12-31; the number of short shares registered in 2024-11-29 reached 54.38 million. The stock has fallen by -11.54% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PACB stock heading into the next quarter.
